From: lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration
LncRNAs | Expression | Functional role | Related factor | Reference |
---|---|---|---|---|
lncRNA-CIR | Up | Aggrecan and collagen degradation | MMP-13 and ADAMTS5 | [15] |
RP11-296A18.3 | Up | Abnormal proliferation of HNPC | miR-138 and HIF1α | [18] |
PART1 | Up | Influence the expression of ACVR1, E2F3, and VEGFA | miR-34a and miR-148a | [19] |
HOTAIR | Up | Overexpression of matrix metalloproteinase | IL-1β | [20] |
CILinc01 and CILinc02 | Down | Influence cytokine production | NF-κB | [21] |
PACER | Up | Influence cytokine production | COX-2 | [22] |
AC005082.12 | Up | ECM degeneration | EFNA3 | [23] |
MEG3 | Down | Vascular invasion | VEGF | [24] |
HCG18 | Up | NP cell apoptosis | miR-146a-5p/TRAF6/NFκB | [25] |
HOTTIP | Up | Chondrogenic differentiation inhibition | HoxA13 | [26] |
GAS5 | Up | Apoptosis of chondrocytes | miR-21 | [27] |
PCGEM1 | Down | Apoptosis of synoviocyte | miR-770 | [28] |
linc-ADAMTS5 | Down | Aggrecan degradation | ADAMTS5 | [29] |
TUG1 | Up | NP cell proliferation inhibition | Wnt β-catenin | [30] |
LncRNA-MSR | Up | Overexpression of metalloproteinase | miR-152 | [31] |
DANCR | Down | Chondrogenic differentiation inhibition | smad3 and STAT3 | [32] |